Stay updated on Combination Dato-DXd Clinical Trial
Sign up to get notified when there's something new on the Combination Dato-DXd Clinical Trial page.

Latest updates to the Combination Dato-DXd Clinical Trial page
- ChecktodayChange DetectedThe page has been updated to reflect an increase in the number of study locations from 239 to 240, and the revision version has been updated from v2.15.0 to v2.16.0.SummaryDifference0.5%
- Check38 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed study information regarding the efficacy and safety of datopotamab deruxtecan in combination with pembrolizumab for advanced non-small cell lung cancer, and the addition of new identifiers and collaborators related to the study.SummaryDifference20%
- Check71 days agoChange DetectedThe page now indicates that the study has increased to 238 locations, with a specific mention of Cankaya, Turkey, as a new location. Additionally, the last update date has changed to March 2025, reflecting the most recent information.SummaryDifference0.5%
- Check135 days agoChange DetectedThe website has updated to version v2.14.0, adding a 'Contact: Principal Investigator' section and a new 'Type of intervention' feature, while removing the previous version's 'type of intervention' and reverting to an earlier revision.SummaryDifference11%
- Check157 days agoChange DetectedThe study has increased from 236 to 237 locations, with the latest revision updated to v2.13.3.SummaryDifference0.4%
- Check164 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information on who can answer questions about joining the study and where it is taking place, with a reference to the Contacts and Locations section.SummaryDifference1.0%
Stay in the know with updates to Combination Dato-DXd Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combination Dato-DXd Clinical Trial page.